drugset / Trial / NCT00203385

Maintenance Phase Treatment With Divalproex for Post Traumatic Stress Disorder

NCT00203385 ↗

NaSingle-groupOpen-labelTreatment

Summary

The primary objective is to evaluate the long-term efficacy of divalproex sodium (Depakote) in the continuation treatment of PTSD.

Timeline

Start
2003-05
Primary completion
2005-03
Completion
2005-03

Outcome

Outcome not reported

Stopped (Business): “Funding expired”

Drugs

EvaluationDrugModalityDoseRoute
Subject Divalproex Sodium Small molecule 2000 mg Oral